RCM
IMGN

Raleigh Capital Management’s Immunogen Inc IMGN Stock Holding History

Raleigh Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-162
Closed -$4.8K – 1208
2023
Q4 		$4.8K Sell
162
-163
-50% -$3.25K ﹤0.01% 741
2023
Q3 		$5.16K Buy
325
+40
+14% +$665 ﹤0.01% 682
2023
Q2 		$5.38K Buy
+285
New +$3.37K ﹤0.01% 630

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Raleigh Capital Management's IMGN Position: Q1 2024 in Review

Raleigh Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 162 shares — an estimated $4.8K sold.

Raleigh Capital Management first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $5.38K in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Raleigh Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Raleigh Capital Management sold 162 Immunogen Inc shares in Q1 2024, an estimated $4.8K.
  • Raleigh Capital Management first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Raleigh Capital Management's Immunogen Inc position peaked at $5.38K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Raleigh Capital Management's 13F filing for Q1 2024, filed 13 May 2024.